SOX2 and neoplasm: To further reinforce the notion that SOX2 is a novel downstream mediator of TAZ in HNSCC tumorigenesis, especially in the CSCs maintenance, we next performed rescue experiments and tumor-initiating assay via in vivo xenograft animal model.